Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

10.52
Delayed Data
As of Jan 20
 -0.03 / -0.28%
Today’s Change
7.90
Today|||52-Week Range
14.15
-1.68%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close10.55
Today’s open10.56
Day’s range10.37 - 10.66
Volume670,945
Average volume (3 months)895,530
Market cap$1.1B
Dividend yield9.51%
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+427.50%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio30.1
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.05-0.21%
PBYIPuma Biotechnology I...-3.25-9.15%
EBSEmergent BioSolution...+0.10+0.34%
DEPODepomed Inc-0.26-1.44%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs